Document is current

Article History

Received: 14 January 2025

Revised: 23 March 2025

Accepted: 31 March 2025

First Online: 11 April 2025

Declarations

:

: All procedures performed in studies involving human participants were approved by the local ethics committee of the University of Tuebingen and we in accordance with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

: Since only anonymised data was evaluated retrospectively, no informed consent was required according to feedback from the ethics committee.

: Focke Ziemssen has received research grants from DFG, Acylerin, Bayer, Clearside, Kodiak, Johnson&Johnson, Novartis, Ophtea, Regeneron, Roche, Sandoz and speaker honoraria from Allergan/Abbvie, Bayer Healthcare, CME Health, Novartis, ODOS, Roche and Sanofi. Consultancy services were provided for Allergan/Abbvie, Apellis, Alimera, Bayer Healthcare, Biogen, Boehringer-Ingelheim, Roche/Genentech, Johnson&Johnson, NovoNordisk, MSD, Oxurion and Sandoz. All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.